Kyle Rasbach
Chief Financial Officer, Lexeo Therapeutics, Inc.
Companies
- Lexeo Therapeutics, Inc.Chief financial officer Dec 27, 2024 to Jan 22, 20251
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Lexeo Therapeutics, Inc. LXEO40,875 shares2$112.8K at $2.76Jan 17, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 17, 2025Granted 40,875 shares of Lexeo Therapeutics, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2